Lipoxygenase Inhibitory Activity Evaluation of Achillea Biebersteinii Afan. by Activity-Guided Fractionation

dc.contributor.author Bedir, Erdal
dc.contributor.author Gunbatan, Tugba
dc.contributor.author Gurbuz, Ihan
dc.contributor.author Dilmac, Elif
dc.contributor.author Bedir, Erdal
dc.contributor.author Demirci, Fatih
dc.contributor.other 03.01. Department of Bioengineering
dc.contributor.other 03. Faculty of Engineering
dc.contributor.other 01. Izmir Institute of Technology
dc.date.accessioned 2025-12-25T21:39:41Z
dc.date.available 2025-12-25T21:39:41Z
dc.date.issued 2026
dc.description.abstract Ethnopharmacological relevance: Achillea biebersteinii Afan. is traditionally utilized as folk medicine for a broad range of therapeutic applications, especially for promoting the maturation of abscesses, wound healing; against inflammation, and rheumatism in T & uuml;rkiye. Aim of the study: The anti-inflammatory potential of A. biebersteinii was evaluated through activity-guided fractionation (AGF) targeting lipoxygenase (15-LOX) inhibition. Materials and methods: Different chromatographic techniques were used for the AGF of the ethyl acetate extract of A. biebersteinii aerial parts. The in vitro 15-LOX inhibitory activity evaluation was performed to address the antiinflammatory activity. The structures of purified compounds from the fractions were confirmed by LC-HRMS, 1H NMR, and 13C NMR analyses, respectively. Results: The fractionation and isolation process culminated in the identification of three key flavonoids namely; patulitrin, axillarin, quercetagetin-7-O-beta-glucopyranoside, and 4,5-dicaffeoylquinic acid, which showed statistically remarkable 15-LOX inhibitory activity with inhibition rates of 82.27%, 96.81 %, 84.65% and 77.47 %, respectively. Two flavonoids were isolated by using the AGF method, where quinic acid was spotted to have significant 15-LOX inhibitory activity. Conclusion: These findings support the future therapeutic potential of A. biebersteinii as a natural antiinflammatory source. en_US
dc.identifier.doi 10.1016/j.jep.2025.120900
dc.identifier.issn 0378-8741
dc.identifier.issn 1872-7573
dc.identifier.scopus 2-s2.0-105023667036
dc.identifier.uri https://doi.org/10.1016/j.jep.2025.120900
dc.identifier.uri https://hdl.handle.net/11147/18776
dc.language.iso en en_US
dc.publisher Elsevier Ireland Ltd en_US
dc.relation.ispartof Journal of Ethnopharmacology en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Achillea Biebersteinii en_US
dc.subject Patulitrin en_US
dc.subject Axillarin en_US
dc.subject Quercetagetin-7-O-Beta-Glucopyranosidne en_US
dc.subject 4, 5-Dicaffeoylquinic Acid en_US
dc.subject Lipoxygenase en_US
dc.subject Anti-Inflammatory en_US
dc.title Lipoxygenase Inhibitory Activity Evaluation of Achillea Biebersteinii Afan. by Activity-Guided Fractionation en_US
dc.type Article en_US
dspace.entity.type Publication
gdc.author.scopusid 59925410100
gdc.author.scopusid 57188819718
gdc.author.scopusid 6602792411
gdc.author.scopusid 57216417618
gdc.author.scopusid 7003998497
gdc.author.scopusid 35071145000
gdc.author.wosid Demirci, Fatih/Jmp-7081-2023
gdc.author.wosid Günbatan, Tuğba/Aha-9058-2022
gdc.coar.type text::journal::journal article
gdc.collaboration.industrial false
gdc.description.department İzmir Institute of Technology en_US
gdc.description.departmenttemp [Subasi, Bilgen] Minist Natl Def Pharmaceut Factory Directorate, TR-06110 Ankara, Turkiye; [Gunbatan, Tugba; Gurbuz, Ihan; Bedir, Erdal] Gazi Univ, Fac Pharm, Dept Pharmacognosy, TR-06330 Ankara, Turkiye; [Dilmac, Elif] Izmir Inst Technol, Dept Bioengn, TR-35430 Izmir, Turkiye; [Demirci, Fatih] Anadolu Univ, Fac Pharm, Dept Pharmacognosy, TR-26470 Eskisehir, Turkiye en_US
gdc.description.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
gdc.description.scopusquality Q1
gdc.description.volume 357 en_US
gdc.description.woscitationindex Science Citation Index Expanded
gdc.description.wosquality Q1
gdc.identifier.openalex W4416303479
gdc.identifier.pmid 41241211
gdc.identifier.wos WOS:001621798800001
gdc.index.type WoS
gdc.index.type Scopus
gdc.index.type PubMed
gdc.openalex.collaboration National
gdc.opencitations.count 0
gdc.plumx.scopuscites 0
gdc.scopus.citedcount 0
gdc.wos.citedcount 0
relation.isAuthorOfPublication 461a570d-2493-4349-b634-a876ced8cd22
relation.isAuthorOfPublication.latestForDiscovery 461a570d-2493-4349-b634-a876ced8cd22
relation.isOrgUnitOfPublication 9af2b05f-28ac-4015-8abe-a4dfe192da5e
relation.isOrgUnitOfPublication 9af2b05f-28ac-4004-8abe-a4dfe192da5e
relation.isOrgUnitOfPublication 9af2b05f-28ac-4003-8abe-a4dfe192da5e
relation.isOrgUnitOfPublication.latestForDiscovery 9af2b05f-28ac-4015-8abe-a4dfe192da5e

Files